Report by Clarivate entitled Protein degraders enabling precision interventions for 'undruggable' targets, Companies to Watch 2025, published on 8 October, 2025.
In a report by leading global business information provider Clarivate, Beactica Therapeutic is highlighted as one of six emerging innovators changing the drug discovery and development paradigm by using protein degradation to develop precision interventions for 'undruggable' targets.
The full report can be downloaded here.
Stay Updated
Sign up for the Beactica newsletter to receive our latest news and updates